The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment
暂无分享,去创建一个
A. Karasik | D. Seidman | I. Ben-Shlomo | J. Dor | S. Mashiach | D. Levran
[1] Z. Ben-Rafael,et al. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG , 1991, Journal of in Vitro Fertilization and Embryo Transfer.
[2] I. Ben-Shlomo,et al. Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery , 1990, Journal of in Vitro Fertilization and Embryo Transfer.
[3] T. Bjøro,et al. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders. , 1990, Human reproduction.
[4] M. Davies,et al. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles. , 1989, Human reproduction.
[5] P. Barlow,et al. Fertility prognosis in IVF treatment of patients with cancelled cycles. , 1989, Human reproduction.
[6] F. Bonilla-musoles,et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? , 1989, Human reproduction.
[7] R. Frydman,et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. , 1989, Human reproduction.
[8] R. Frydman,et al. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation , 1988, Fertility and sterility.
[9] S. Muasher. Stimulation Protocols for Patients with “Atypical Response” , 1988, Annals of the New York Academy of Sciences.
[10] R. Edwards,et al. Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme. , 1987, Human reproduction.
[11] B. Tarlatzis,et al. The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. , 1984, Fertility and sterility.
[12] L. Veeck,et al. The importance of the follicular phase to success and failure in in vitro fertilization. , 1983, Fertility and sterility.
[13] C Wood,et al. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. , 1981, Science.
[14] R. Fleming,et al. Correlation of ultrasonic and endocrinologic assessment of human follicular development. , 1979, American journal of obstetrics and gynecology.
[15] G. Kunz,et al. Influence of the duration of the oestradiol rise on the success rate in GnRH analogue/HMG-stimulated IVF cycles. , 1990, Human reproduction.
[16] L. Dalprà,et al. IVF: induction of ovulation in poor responders. , 1989, Journal of steroid biochemistry.
[17] R. Frydman,et al. Utilization of GnRH agonists for poor responders in an IVF programme. , 1989, Human reproduction.
[18] R. Marrs,et al. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. , 1988, Fertility and sterility.
[19] D. Serr,et al. Periovulatory 17 beta-estradiol changes and embryo morphologic features in conception and nonconceptional cycles after human in vitro fertilization. , 1986, Fertility and sterility.
[20] E. Rudak,et al. Periovulatory 17β-estradiol changes and embryo morphologic features in conception and nonconceptional cycles after human in vitro fertilization , 1986 .